Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $112.18 | $24.56 | 356.68% | 211.66x | 192.29x | 14.23x | 17.18x | 1.64x | $106.92M | 0.90% | $705.78M | 6.70 | $12.02B | 1,532.81 | ||
| LQDA | LIQUIDIA CORP | $78.79 | $17.08 | 361.38% | 328.29x | 23.71x | 24.07x | 64.53x | 1.59x | $41.15M | 0.59% | $108.58M | 1.23 | $6.97B | 130.02 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $223.95 | $94.70 | 136.48% | 36.71x | 30.91x | 6.23x | 22.13x | 1.12x | $793.95M | 2.65% | $1.35B | 10.14 | $31.25B | 26.49 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.28 | $8.31 | 216.13% | 125.14x | 163.33x | 7.39x | 14.98x | 1.16x | $39.15M | 1.14% | $220.58M | 1.69 | $3.38B | 74.52 | ||
| RPRX | ROYALTY PHARMA PLC | $59.22 | $38.55 | 53.62% | 31.50x | 11.04x | 10.39x | 3.48x | 0.65x | $2.92B | 11.09% | $9.79B | 21.99 | $42.20B | 35.88 | ||
| ASND | ASCENDIS PHARMA A | $255.46 | $76.32 | 234.73% | 27.08x | 17.56x | 15.58x | 27.64x | 2.82x | $52.94M | 0.33% | $574.09M | 9.24 | $16.25B | 174.23 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.15 | $16.44 | 375.37% | 73.04x | 62.07x | 7.21x | 9.32x | 2.26x | $182.84M | 3.02% | $654.15M | 8.43 | $5.93B | 49.44 | ||
| KRYS | KRYSTAL BIOTECH INC | $332.86 | $86.44 | 285.06% | 40.25x | 43.65x | 22.31x | 7.25x | 2.37x | $257.78M | 2.62% | $1.36B | 46.03 | $9.43B | 40.44 | ||
| ADMA | ADMA BIOLOGICS INC | $9.78 | $8.74 | 11.85% | 13.58x | 11.66x | 4.36x | 5.37x | 0.61x | $116.47M | 5.21% | $408.21M | 1.79 | $2.25B | 9.67 | ||
| HALO | HALOZYME THERAPEUTICS INC | $101.79 | $70.95 | 43.47% | 28.59x | 12.26x | 7.17x | 80.48x | 0.61x | $806.22M | 6.75% | $143.54M | 1.22 | $13.54B | 18.84 | ||
| VCEL | VERICEL CORP | $44.73 | $8.90 | 402.66% | 93.19x | 92.78x | 7.46x | 6.19x | 2.21x | $61.66M | 2.70% | $370.04M | 7.25 | $2.26B | 51.26 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.06 | $2.24 | 36.64% | 15.30x | 13.24x | 1.88x | 2.93x | 0.79x | $5.67M | 2.35% | $82.53M | 1.04 | $177.71M | 9.51 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $70.24 | $21.26 | 230.46% | 184.84x | 18.91x | 3.99x | 2.15x | 1.16x | $738.18M | 5.43% | $6.32B | 32.68 | $16.91B | 43.84 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.44 | $9.45 | 21.03% | 12.04x | 11.05x | 4.97x | 3.12x | 0.78x | $82.01M | 12.12% | $217.65M | 3.68 | $535.53M | 6.93 | ||
| TGTX | TG THERAPEUTICS INC | $49.50 | $23.88 | 107.33% | 16.07x | 35.13x | 8.78x | 12.54x | 1.88x | $17.39M | 0.25% | $604.08M | 4.26 | $7.85B | 56.36 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $293.27 | $93.48 | 213.72% | 29.12x | 31.74x | 20.25x | 6.04x | 2.19x | $130.62M | 2.22% | $967.52M | 48.22 | $5.97B | 21.40 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $248.95 | $194.99 | 27.67% | 16.31x | 9.64x | 3.42x | 3.37x | 0.67x | $1.62B | 10.29% | $4.80B | 75.98 | $18.94B | 11.71 | ||
| TECH | BIO-TECHNE CORP | $72.23 | $15.95 | 352.71% | 101.73x | 34.62x | 9.33x | 5.42x | 1.87x | $269.60M | 2.39% | $2.09B | 13.34 | $11.39B | 44.49 | ||
| MDXG | MIMEDX GROUP INC | $4.28 | $1.11 | 286.35% | 107.00x | -38.15x | 1.78x | 2.89x | 1.51x | $44.50M | 7.03% | $216.00M | 1.46 | $505.22M | 22.15 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.19 | $8.55 | -86.09% | 4.41x | -4.02x | 1.11x | 1.30x | 0.05x | $7.24M | 10.59% | $52.93M | 0.92 | $15.25M | 0.98 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $797.99 | $414.97 | 92.30% | 19.03x | 17.09x | 5.28x | 2.59x | 1.25x | $3.76B | 4.58% | $31.71B | 308.48 | $82.41B | 14.33 | ||
| UTHR | UNITED THERAPEUTICS CORP | $511.72 | $223.59 | 128.86% | 16.92x | 18.70x | 6.91x | 19.59x | 2.28x | $1.09B | 5.01% | $6.40B | 150.24 | $123.57B | 73.71 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $525.73 | $157.13 | 234.57% | 30.34x | 27.19x | 10.60x | 6.58x | 2.40x | $3.80B | 2.85% | $20.25B | 79.81 | $129.09B | 23.46 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.77 | $32.80 | 21.24% | 12.67x | 10.48x | 2.40x | 2.32x | 0.75x | $354.90M | 15.40% | $999.24M | 17.25 | $1.92B | 6.86 | ||
| EXEL | EXELIXIS INC | $50.38 | $28.43 | 77.19% | 15.31x | 15.66x | 5.19x | 6.77x | 1.35x | $1.17B | 9.28% | $1.84B | 7.35 | $12.37B | 11.37 | ||
| INCY | INCYTE CORP | $120.77 | $60.18 | 100.67% | 14.87x | 15.89x | 4.16x | 3.86x | 1.99x | $1.92B | 7.94% | $6.34B | 31.66 | $20.53B | 9.93 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.